ezetimibe (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the ezetimibe drug offered from Cadila Healthcare Limited. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | ezetimibe |
| SUBSTANCE NAME: | EZETIMIBE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-09 |
| END MARKETING DATE: | 0000-00-00 |
ezetimibe HUMAN PRESCRIPTION DRUG Details:
| Item Description | ezetimibe from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2017-08-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1109_91868a02-7c53-40e3-96e1-75fe16f5e271 |
| PRODUCT NDC: | 70771-1109 |
| APPLICATION NUMBER: | ANDA204331 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers:
